NAD+ therapy helps restore a coenzyme that declines with age and influences energy, DNA repair, and mitochondrial function. A practical guide to uses, routes, costs, and the limits of human evidence.
NAD+ therapy is a medical treatment that delivers nicotinamide adenine dinucleotide intravenously with the aim of increasing systemic availability of this coenzyme and supporting NAD+-dependent pathways involved in energy production, DNA repair, and mitochondrial function.
Your body makes less NAD+ every year after 40, and that matters more than most people realize. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in over 500 enzymatic reactions — from converting food into cellular energy to repairing damaged DNA to activating sirtuins, the family of proteins that regulate aging at the genetic level.
According to Massudi et al. (2012, PMID: 22848760), human tissue NAD+ levels drop by approximately 50% between ages 40 and 60. That decline has been associated with oxidative stress and age-related metabolic change, but it does not by itself explain fatigue, cognitive fog, or chronic inflammation.
NAD+ therapy aims to compensate for part of this decline — usually through intravenous infusion, though oral precursors and subcutaneous injections are also available. Cellular uptake and clinical outcomes still depend on context and remain under study.
Quick answer: what to know about NAD+
- What it is: a coenzyme required for cellular energy, DNA repair and metabolic signaling.
- What the biology suggests: NAD+ availability declines with age and NAD+ metabolites can be raised measurably.
- What is not proven: that an NAD+ infusion reverses aging or extends lifespan in healthy adults.
- Prudent use: review symptoms, biomarkers, medications, kidney/liver function and infusion tolerance.
If you are comparing options, place NAD+ inside a broader medical plan: review the Optimization Program, our treatments, what a longevity clinic should measure and the route to start a plan. The intervention makes more sense when it fits labs, goals and follow-up, not as a standalone drip.
What We Know in 2026: Promising Biology, Not an Anti-Aging Miracle
The missing nuance in many searches for “NAD anti-aging” is simple: raising NAD+ is measurable; proving that this extends lifespan or reverses aging in healthy humans is not there yet. Researchers including Christopher Martens and Shalender Bhasin told NPR Health in May 2026 that the marketing has run ahead of large human trials.
| Clinical question | Short answer | Evidence level |
|---|---|---|
| Does measurable NAD+ rise? | Yes. Trials with oral NR and NMN raise blood NAD+ metabolites; IV NAD+ delivers NAD+ directly, although clinical outcomes for this route are less studied. | Human, small to mid-size samples |
| Does function improve? | There are signals: in the NICE peripheral artery disease trial, NR improved 6-minute walking distance at 6 months versus placebo. | Human, specific setting |
| Does it rejuvenate or extend lifespan? | Not proven in humans. Strong claims usually come from animal models or extrapolated biomarkers. | Insufficient |
| Can it make clinical sense? | It can when fatigue, mitochondrial dysfunction, or a measured medical protocol is present. It should not be sold as a universal drip. | Case-dependent |
That is why Progevita treats NAD+ therapy as a metabolic tool, not a shortcut. First we measure biomarkers; then we decide whether IV NAD+, oral precursors, or neither makes sense.
What NAD+ Does in Your Body (And Why the Decline Matters)
NAD+ isn't a single-purpose vitamin. It's a metabolic intermediary working across three processes simultaneously:
1. Cellular energy production (ATP)
Inside the mitochondria, NAD+ accepts electrons during the Krebs cycle and electron transport chain, driving ATP production — the energy currency of every cell. When NAD+ drops, ATP output falls with it. The result: fatigue, poor recovery, and reduced physical performance.
2. DNA repair
PARP enzymes (poly ADP-ribose polymerases) consume NAD+ each time they fix a DNA strand break. As we age, accumulated DNA damage increases PARP activity, which depletes NAD+ further — creating a vicious cycle of more damage and fewer resources to fix it. Yoshino et al. (Cell Metabolism, 2018, PMID: 29249689) reviewed this pathway as one link between NAD+ metabolism, cellular repair, and aging biology.
3. Sirtuin activation
Sirtuins (SIRT1-7) regulate gene expression, stress response, and cellular longevity. They require NAD+ as a substrate to function. When NAD+ levels fall, sirtuin activity declines — accelerating cellular senescence, increasing inflammation, and impairing autophagy (the cell's internal cleanup system).
These three functions are interconnected. NAD+ doesn't do one or the other — it does all three simultaneously, and when it's depleted, all three deteriorate together.
Routes of Administration: IV, Oral, Injectable
Not all methods of taking NAD+ are equally effective. The administration route determines how much actually reaches your cells.
Intravenous (IV) infusion
IV NAD+ is the most direct way to deliver NAD+ into the bloodstream, but human evidence for this route is thinner than for oral precursors. A retrospective Frontiers in Aging study in 2026 compared four consecutive days of IV NAD+ versus IV NR in a commercial setting: the NAD+ group reported more gastrointestinal symptoms, higher heart rate, and chest pressure during infusion, with longer average infusion times (97 versus 37 minutes); 30-day safety markers did not show meaningful adverse changes. The practical read is cautious: reasonable short-term tolerability under supervision, not proof of anti-aging efficacy. Sessions typically last 1-3 hours depending on dose (usually 250-500 mg per session). The infusion runs slowly because rapid delivery can cause nausea, facial flushing, or chest tightness.
Oral supplementation (NMN, NR)
Oral NAD+ precursors — nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) — are the most accessible option. Igarashi et al. (NPJ Aging, 2022, PMID: 35927255) showed that chronic NMN supplementation raises blood NAD+ levels in healthy older men. A multicenter trial with 80 adults (Yi et al., 2023, PMID: 36482258) confirmed safety and dose-dependent NAD+ elevation with oral NMN at 300, 600, and 900 mg/day.
The less marketable finding matters too: a 2024 systematic review and meta-analysis of 12 randomized trials found that NMN raises blood NAD+ levels, but did not show significant improvements in glucose or lipid metabolism versus placebo. Moving a biomarker is not the same as improving a clinical outcome.
The trade-off: oral bioavailability is variable, and some of the molecule degrades in the digestive tract. For maintenance goals, oral works well. For supervised interventions (severe fatigue, post-viral recovery, intensive longevity protocols), IV allows controlled administration and closer monitoring, but it has not been proven to deliver better clinical outcomes than oral NR or NMN in healthy humans.
Subcutaneous injection
Some clinics offer NAD+ via subcutaneous auto-injectors. This is a middle-ground option for bioavailability and convenience, though clinical evidence is more limited than for IV or oral routes.
NAD+ Administration Routes Compared
| Feature | IV | Oral (NMN/NR) | Subcutaneous |
|---|---|---|---|
| Exposure | Direct bloodstream exposure; cellular uptake and clinical outcomes still under study | Moderate and variable; better studied for oral NR/NMN | Intermediate; fewer published data |
| Onset of effect | Minutes | Days to weeks | Hours |
| Session duration | 1-3 hours | Daily, oral | 5-10 minutes |
| Typical dose | 250-500 mg | 250-1000 mg/day | 50-100 mg |
| Medical supervision | Required | Not required | Recommended |
| Approximate cost | €200-500/session | €40-120/month | €100-300/month |
| Best suited for | Acute intervention | Daily maintenance | Middle ground |
How to Decide: IV, Oral NR/NMN, or No NAD+ Yet
The real question is not “NAD+ yes or no?” It is what problem you are trying to solve, which biomarker will show progress, and whether the cost and risk make sense.
| Situation | Most reasonable option | Why |
|---|---|---|
| Healthy person, no symptoms, anti-aging curiosity only | Do not start with IV NAD+ | Prioritize sleep, strength, VO2, glucose, blood pressure, and nutrition; the incremental benefit is not proven. |
| Maintenance goal with lower risk and moderate cost | Supervised oral NR/NMN | More convenient and supported by more human trials for raising NAD+ metabolites. |
| Severe fatigue, slow recovery, suspected mitochondrial dysfunction | Consider IV NAD+ inside a medical protocol | Allows controlled administration, vital-sign monitoring during infusion, and follow-up. |
| No biomarkers or clinical goal | Do not treat yet | Without a baseline, you cannot know whether you improved or simply paid for a sensation. |
Who Benefits from NAD+ Therapy
NAD+ therapy is not a treatment for a specific disease; it is a metabolic intervention that can make sense in several contexts, as long as there is medical evaluation and measurable goals:
Chronic fatigue and low energy: when mitochondrial dysfunction or slow recovery is suspected, supporting NAD+-dependent pathways can be part of a broader protocol. Some patients report better energy or sleep, but response is individual and should be checked against objective metrics.
Post-viral recovery: after prolonged infections (including long COVID), some patients show residual mitochondrial dysfunction. NAD+ therapy has been explored as support for cellular energy recovery, though controlled clinical trials in this area remain limited.
Neurodegenerative conditions: preclinical studies show that NAD+ deficiency contributes to neuronal dysfunction in Alzheimer's and Parkinson's models. A pilot trial with NR in 20 older adults with mild cognitive impairment (Orr et al., GeroScience, 2024, PMID: 37994989) found a 2.6-fold rise in blood NAD+ and good tolerability, but no cognitive improvement over 10 weeks. Larger and longer trials are needed.
Longevity and anti-aging: within the framework of the 12 hallmarks of aging (López-Otín et al., Cell, 2023, PMID: 36599349), NAD+ decline connects directly to at least three: mitochondrial dysfunction, epigenetic alterations, and genomic instability. Restoring NAD+ doesn't "reverse" aging, but it addresses specific mechanisms that speed it up.
Athletic performance: athletes looking to improve post-training recovery and mitochondrial function use NAD+ as part of performance protocols. Kimura et al. (2024, PMID: 38789831) found that 12-week NMN supplementation in older adults maintained walking speed and improved sleep quality.
When It Is Not Worth It — or Needs Medical Review First
NAD+ therapy should not be your first lever if you sleep 5 hours, do no strength training, rely on ultra-processed food, or have uncontrolled glucose or blood pressure. It also should not be done because it is fashionable, without baseline labs, or without a measurable outcome.
Individual medical review is essential during pregnancy or breastfeeding, active cancer or oncology treatment, arrhythmias or unstable cardiovascular disease, significant kidney or liver disease, prior IV-infusion reactions, or complex medication use. In those cases, NAD+ should not be improvised; it should be coordinated with the clinician responsible for care.
Red Flags in NAD+ Clinics or Ads
Be cautious with any provider promising to “reverse aging”, “regenerate the brain”, cure addiction, or replace medical treatment. In 2025, The Guardian investigated UK clinics selling NAD+ infusions for addiction with unproven claims and possible regulatory problems. The responsible version is much less spectacular: specific indication, informed consent, medical supervision, adverse-event tracking, and follow-up data.
A good consultation should be able to explain which evidence belongs to oral NR/NMN, which evidence belongs to IV NAD+, what is known about short-term safety, what is not known yet, and what the team would do if nausea, palpitations, or chest pressure appeared during infusion.
What to Measure to Know Whether It Is Working
The serious way to evaluate NAD+ is not to ask “do I feel younger?” It is to compare baseline and follow-up. Useful metrics include:
| Area | What to measure | Response signal |
|---|---|---|
| Energy and fatigue | Fatigue scale, daily energy, effort tolerance | Sustained lower fatigue, not just 24-hour euphoria |
| Physical function | 6-minute walk test, walking speed, grip strength | Reproducible functional improvement |
| Sleep and recovery | Sleep quality, HRV, resting heart rate | Better recovery without overstimulation |
| Metabolism and inflammation | Glucose/HbA1c, blood pressure, body composition, suPAR, Oxytest | Changes consistent with the full plan, not attributed only to the drip |
What to Expect During and After an IV Session
The experience is straightforward but requires patience.
Before: a medical assessment rules out contraindications. Basic vital signs are taken. No fasting is required, though good hydration is recommended.
During: you sit in a reclining chair with an IV line. The infusion runs slowly over 1-3 hours. Many patients read, work, or rest during the process. If the infusion rate is too high, you may experience facial flushing, mild nausea, or chest pressure — all resolved by slowing the drip.
After: effects aren't immediate or dramatic after the first session. Some patients report better mental clarity and energy within 24-48 hours. Cumulative benefits usually become noticeable from the third or fourth session onwards.
Typical protocol: 4-8 initial sessions (one or two per week), followed by maintenance sessions every 2-4 weeks based on individual response and patient goals.
Side effects: usually depend on infusion speed. They include nausea, transient facial flushing, injection-site discomfort, mild headache and, in some patients, palpitations or chest pressure during the drip. Available IV evidence is short-term and based on small samples; that is why medical supervision and patient selection matter.
How We Use NAD+ Therapy at Progevita
At Progevita, NAD+ therapy isn't a standalone service you book and forget. It's one component within an integrated longevity protocol.
Our NAD+ drip ("Energy Boost") is administered intravenously under medical supervision within the Orthomolecular Medicine Unit. Sessions last approximately 30-40 minutes and integrate within our residential programs (Optimization Program from €1,350, Inflammaging from €1,470, Leadership Path from €1,640).
What makes our approach different:
We measure before we treat. We don't administer NAD+ by default. First, we evaluate biomarkers for oxidative stress (Oxytest), inflammation (suPAR), body composition, and metabolic profile to determine whether your mitochondrial deficit justifies the intervention.
We integrate it deliberately. NAD+ therapy can sit alongside ozone therapy (antioxidant pathways such as Nrf2), plasmapheresis (reducing inflammatory load in selected profiles), and a personalized nutrition and exercise plan when the case supports it. We do not assume that stacking treatments is better by default: we define the goal, biomarker, and follow-up.
12-month follow-up. After your stay, you receive a maintenance plan that may include oral NAD+ precursor supplementation (NMN or NR) and follow-up sessions to evaluate whether your biomarkers have responded.
Progevita operates at the Balneario de Cofrentes, Valencia, with a team of over 50 medical professionals. We're not a hotel with a nurse setting up drips — we're a longevity clinic with advanced diagnostics, where every treatment responds to data, not trends.
If you want the bigger picture, start with about us, the clinic page and the Optimization and Inflammaging programmes.
Want to know if NAD+ therapy is right for you? Book your consultation at Progevita and start with the data.
Frequently Asked Questions About NAD+ Therapy
What exactly is NAD+ and why does it decline with age?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell that participates in energy production, DNA repair, and sirtuin activation. Levels fall by approximately 50% between ages 40 and 60 (Massudi et al., 2012) due to increased consumption by repair enzymes (PARPs) and reduced endogenous synthesis.
How many IV NAD+ sessions are needed?
A typical initial protocol includes 4-8 sessions (one or two per week), followed by maintenance every 2-4 weeks. Response varies by individual and depends on baseline status, age, and goals.
Is IV NAD+ therapy safe?
For oral NMN and NR, trials such as Yi et al. (2023) and Igarashi et al. (2022) report a favorable short-term safety profile. For IV NAD+, the human evidence base is smaller: the 2026 Frontiers in Aging study observed gastrointestinal symptoms, higher heart rate, and chest pressure during infusion, resolved after completion, with no meaningful 30-day safety-marker changes. That is not the same as proven long-term safety.
Does NAD+ therapy extend lifespan?
There is no proof that IV NAD+, NMN, or NR extends lifespan in healthy humans. What human studies do show is higher blood NAD+ and some functional signals in specific groups. For longevity, it should be treated as support for cellular mechanisms, not a replacement for exercise, sleep, nutrition, and cardiometabolic risk control.
What's the difference between oral NMN and IV NAD+?
Oral NMN is a precursor that the body converts to NAD+. Bioavailability is lower and the effect is gradual (days to weeks). IV delivers NAD+ directly into the bloodstream, with faster effect but requires medical supervision. They're complementary: IV for acute intervention, oral for maintenance.
How much does NAD+ therapy cost?
Pricing varies by clinic and dose. At Progevita, the NAD+ drip is included within residential programs (from €1,350 for 4 nights, which includes accommodation, meals, medical consultations, diagnostics, and treatments). As an individual add-on, orthomolecular IV drips carry an additional cost based on the prescribed protocol.
Can NAD+ therapy be combined with other longevity treatments?
Yes, but not by automatically stacking treatments. At Progevita it may be integrated, depending on the case, with ozone therapy, plasmapheresis, advanced diagnostics, and a personalized 12-month plan covering exercise, nutrition, and sleep.
At what age should you consider NAD+ therapy?
There's no fixed minimum age, but the significant decline in NAD+ begins around age 40. From that point on, if you're experiencing fatigue, cognitive decline, or slow recovery, it makes sense to evaluate your biomarkers and consider intervention.
NAD+ has become a symbol of modern biohacking. The serious question is not whether it sounds advanced, but whether it fits a measured protocol. We explain the broader filter in our guide to what biohacking is and how to separate science from marketing.
References
- Massudi H et al., "Age-associated changes in oxidative stress and NAD+ metabolism in human tissue", PLoS One, 2012 (PMID: 22848760)
- Yoshino J et al., "NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR", Cell Metabolism, 2018 (PMID: 29249689)
- Martens CR et al., "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults", Nature Communications, 2018 (PMID: 29599478)
- McDermott MM et al., "Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial", Nature Communications, 2024 (DOI: 10.1038/s41467-024-49092-5)
- NPR Health, "Marketers say NAD+ pills and infusions can boost longevity. What's the evidence?", 2026
- Frontiers in Aging, "Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting", 2026 (DOI: 10.3389/fragi.2026.1652582)
- Rajman L et al., "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence", Cell Metabolism, 2018 (PMID: 29514064)
- Igarashi M et al., "Chronic nicotinamide mononucleotide supplementation elevates blood NAD+ levels and alters muscle function in healthy older men", NPJ Aging, 2022 (PMID: 35927255)
- Yi L et al., "The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial", GeroScience, 2023 (PMID: 36482258)
- "Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism, blood NAD levels and physical performance: a systematic review and meta-analysis", Critical Reviews in Food Science and Nutrition, 2024 (DOI: 10.1080/10408398.2024.2387324)
- The Guardian, "It's not ethical and it's not medical: how UK rehab clinics are cashing in on NAD", 2025
- Orr ME et al., "A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment", GeroScience, 2024 (PMID: 37994989)
- Kimura S et al., "Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults", GeroScience, 2024 (PMID: 38789831)
- López-Otín C et al., "Hallmarks of aging: An expanding universe", Cell, 2023 (PMID: 36599349)
- Campbell JM, "Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts", Nutrients, 2022 (PMID: 35956406)
This article is for informational purposes and does not replace medical consultation. Any NAD+ treatment should be prescribed and supervised by a qualified healthcare professional.